title: The fibroblast growth factor family: neuromodulation of affective behavior.
abstract: In this review, we propose a broader view of the role of the fibroblast growth factor (FGF) family in modulating brain function. We suggest that some of the FGF ligands together with the FGF receptors are altered in individuals with affective disorder and modulate emotionality in animal models. Thus, we propose that members of the FGF family may be genetic predisposing factors for anxiety, depression, or substance abuse; that they play a key organizing role during early development but continue to play a central role in neuroplasticity in adulthood; and that they work not only over extended time frames, but also via rapid signaling mechanisms, allowing them to exert an "on-line" influence on behavior. Therefore, the FGF family appears to be a prototype of "switch genes" that are endowed with organizational and modulatory properties across the lifespan, and that may represent molecular candidates as biomarkers and treatment targets for affective and addictive disorders.
authors.affiliation: Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, MI 48109, USA. caturner@umich.edu
authors.forename: Cortney A
authors.initials: CA
authors.lastname: Turner
authors.forename: Stanley J
authors.initials: SJ
authors.lastname: Watson
authors.forename: Huda
authors.initials: H
authors.lastname: Akil
mesh_terms: D000818:Animals; D001921:Brain / Q000503:physiopathology*; D005346:Fibroblast Growth Factors / Q000502:physiology*; D020022:Genetic Predisposition to Disease; D006801:Humans; D019964:Mood Disorders / Q000235:genetics* / Q000503:physiopathology*; D018377:Neurotransmitter Agents / Q000502:physiology*
chemical_list: D018377:Neurotransmitter Agents; D005346:Fibroblast Growth Factors